Medidrink Plus

 

If you would like to know what makes the 4 features characterising MediDrink Plus so beneficial and how they help to achieve a faster recovery.


Disease - related malnutrition

Scientific references

Medidrink leaflet

Scientific studies


High energy


Patients suffering from diseases often cannot consume bigger quantities at once even though the body needs more energy to heal and recover.

Loss of appetite may come down to several reasons, such as side-effects of treatment, dietary restrictions, depression, or pain. However, there is an extremely high demand for energy in the body in order to successfully fight disease in addition to maintaining ordinary functions. (If you would like to read more on the subject, please click on Disease-related malnutrition on the MediFood home page.)

This loss of appetite combined with the increased nutritional needs may lead to Cachexia, or wasting syndrome. Cachexia is the final stage of the process of malnutrition. It is characterized by muscle atrophy, fatigue, weakness and above all an involuntary loss of body mass that is difficult to be reversed nutritionally. So, even if the patient eats more, lean body mass will be lost indicating that a primary pathology is in place. If the patient has cachexia, the chance of serious consequences from the underlying condition is increased dramatically. Therefore it is crucial to prevent or treat this condition by medical nutrition.

An increased energy intake is beneficial for patients for several reas

Consequently, a high energy intake must be provided in a small volume format, so that patients will get the energy they need without having to eat more than they are willing or able to.

The energy level of MediDrink Plus is among the highest on the market with a value of 200kcal in 100ml, this means a 40 to 50kcal more than most of the competitors’ products.


High protein


Proteins are crucial for the body to function properly. They provide and store energy, dissolve other nutrients and control chemical reactions. They are responsible for the growth and repair of body cells and tissues and thus play a major role in fighting disease and in the healing process. However, in case of severe malnourishment the body starts to break down the proteins found in muscles in order to provide the energy it needs (see the High energy section). This temporary solution however has very destructive effects in the long run as the decreased level of proteins make it extremely problematic for the body to function properly and lead to loss of mass and muscle weight. Furthermore, a reduced nutritional intake combined with metabolic changes often lead to chronic negative protein balance in patients suffering from cachexia.

In short, maintaining the optimal protein balance is crucial for patients suffering from any illness.

Containing 16 grams of protein per 200ml, MediDrink Plus supplies this majorly beneficial high protein intake. It is also more than many of our competitors can provide.


High Omega-3


Omega-3 fatty acids are essential fatty acids, meaning that they cannot be synthesized by the human body. However, their sufficient intake is crucial as they are vital for normal metabolism.

A minimum daily intake of 1.5 grams of Omega-3 fatty acids for a prolonged time improved clinical, biological and functional abilities and lead to a higher quality of life in patients suffering from advanced cancer.1 The Polyunsaturated Omega-3 fatty acids have also been clinically proven to be effective against tumour growth and in reducing the rate of the related tissue loss.

MediDrink Plus contains a high level of Omega-3 fatty acids thus contributing to your medical treatment in a number of ways.


High fat-source energy


This feature is especially beneficial for cancer patients as it has been clinically proven that cells of tumour tissues tend to use more carbohydrates to provide energy for themselves as opposed to fat-source energy. 1

Unlike normal cells, most malignant cells need high amounts of glucose which is readily available from blood for energy, and for the forming of tumour tissues, while they are frequently incapable of breaking down significant amounts of fatty acids and ketones2 – intermediates of fatty acid breakdown. Thus, energy – sourced from fatty acids – is provided rather for normal cells than for malignant ones.

Research has also shown that chronically high blood sugar and insulin level advances the formation of tumours and reduces the chance for positive outcome of treatment.3 This high blood sugar and insulin level is generally a consequence of diets mostly containing carbohydrates (potato, rice, pasta, bread, sweets etc…).

COPD patients also benefit from fat-source energy. Since less carbon-dioxide is produced from the metabolism of fatty acids than of carbohydrates, pulmonary load is lower which is beneficial for COPD patients who already have reduced lung functions.

Thus, providing energy from sources other than carbohydrates has a number of positive effects in many different conditions.

The fat source energy of MediDrink Plus is probably the highest on the market of general SIP feeds with a value of 58.10%, as opposed to the average of approximately 25-35% of competitors’ products thus may resulting in a better “anti-cancer” and beneficial COPD effect according to literature findings.


Disease - related malnutrition


Scientific references

  • Colin E. Champ et Al.: Nutrient Restriction and Radiation Therapy for Cancer Treatment: When Less is More; The Oncologist; 2013; 18, 97-103
  • Rainer J Klement, Ulrike Kammerer: Is There a Role for Carbohydrate Restriction in the Treatment and Prevention of Cancer?; Nutritional Metabolism; 2011; 8; 75
  • Attilio Giacosa, Mariangela Rondanelli: Fish oil and treatment of cancer cachexia; Genes Nutrition; 2008; 2, 25-28.
  • Josep M et al.: Optimal management of cancer anorexia – cachexia syndrome; Cancer Management and Research; 2010
  • MD barber et al.: Cancer cachexia; Surgical oncology;1999;42;133-141
  • Barber et al.: Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia;
  • Nutrition and cancer; 2001; 40; 118-24
  • Wigmore et al.: The Effect of Polyunsaturated Fatty Acids on the Progress of Cachexia in Patients With Pancreatic Cancer;
  • Nutrition; 1996; 12; S27-S30
  • Tisdale et al.: Inhibition of tumour-induced lipolysis is vitro and cachexia and tumour growth in vivo by eicosapentaeonic acid;
  • Biochemical pharmacology; 1991; 41; 103-10.
  • Scientific references:
  • Attilio Giacosa, Mariangela Rondanelli: Fish oil and treatment of cancer cachexia; Genes Nutrition; 2008; 2, 25-28.
  • Josep M et al.: Optimal management of cancer anorexia – cachexia syndrome; Cancer Management and Research; 2010
  • MD barber et al.: Cancer cachexia; Surgical oncology;1999;42;133-141
  • Barber et al.: Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia;
  • Nutrition and cancer; 2001; 40; 118-24
  • Wigmore et al.: The Effect of Polyunsaturated Fatty Acids on the Progress of Cachexia in Patients With Pancreatic Cancer;
  • Nutrition; 1996; 12; S27-S30
  • Tisdale et al.: Inhibition of tumour-induced lipolysis is vitro and cachexia and tumour growth in vivo by eicosapentaeonic acid;
  • Biochemical pharmacology; 1991; 41; 103-10.

Scientific studies